13D Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-419,284
| Closed | -$3.65M | – | 29 |
|
|
2024
Q1 | $3.65M | Buy |
419,284
+51,635
| +14% | +$450K | 2.23% | 27 |
|
|
2023
Q4 | $4.21M | Buy |
367,649
+333,348
| +972% | +$3.81M | 2.47% | 28 |
|
|
2023
Q3 | $330K | Sell |
34,301
-476,806
| -93% | -$4.59M | 0.21% | 27 |
|
|
2023
Q2 | $5.44M | Sell |
511,107
-22,455
| -4% | -$239K | 2.97% | 16 |
|
|
2023
Q1 | $5.61M | Hold |
533,562
| – | – | 2.85% | 19 |
|
|
2022
Q4 | $6.61M | Sell |
533,562
-66,869
| -11% | -$829K | 3.48% | 11 |
|
|
2022
Q3 | $6.22M | Hold |
600,431
| – | – | 3.25% | 13 |
|
|
2022
Q2 | $6.92M | Buy |
600,431
+37,328
| +7% | +$430K | 3.06% | 18 |
|
|
2022
Q1 | $7.08M | Sell |
563,103
-49,750
| -8% | -$626K | 2.69% | 19 |
|
|
2021
Q4 | $7.15M | Sell |
612,853
-37,602
| -6% | -$438K | 2.74% | 21 |
|
|
2021
Q3 | $8.49M | Hold |
650,455
| – | – | 3.16% | 17 |
|
|
2021
Q2 | $8.37M | Sell |
650,455
-7,562
| -1% | -$97.3K | 2.88% | 21 |
|
|
2021
Q1 | $7.36M | Buy |
658,017
+287,582
| +78% | +$3.22M | 2.73% | 24 |
|
|
2020
Q4 | $4.22M | Sell |
370,435
-65,887
| -15% | -$751K | 1.74% | 28 |
|
|
2020
Q3 | $3.93M | Buy |
436,322
+5,678
| +1% | +$51.1K | 1.73% | 26 |
|
|
2020
Q2 | $4.44M | Sell |
430,644
-17,324
| -4% | -$179K | 1.93% | 25 |
|
|
2020
Q1 | $4.52M | Buy |
447,968
+27,215
| +6% | +$275K | 2.2% | 23 |
|
|
2019
Q4 | $5.6M | Sell |
420,753
-92,162
| -18% | -$1.23M | 1.7% | 25 |
|
|
2019
Q3 | $4.4M | Buy |
512,915
+23,385
| +5% | +$201K | 1.45% | 21 |
|
|
2019
Q2 | $5.36M | Buy |
+489,530
| New | +$5.36M | 1.61% | 25 |
|